---
schema_version: "secwatch.filing_event.v1"
accession: "0001099800-25-000046"
form_type: "8-K"
ticker: "EW"
cik: "0001099800"
company_name: "Edwards Lifesciences Corp"
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T18:53:27.017620+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# FTC moves to block Edwards' proposed JenaValve acquisition; Edwards raises FY2025 adjusted EPS guidance to $2.45-$2.55

## Summary
- FTC moved to block Edwards' proposed acquisition of JenaValve Technology; Edwards disagrees and will continue pursuing regulatory approval.
- Edwards estimates a final determination on the acquisition by end of Q1 2026.
- Full-year 2025 adjusted EPS guidance raised to high-end of $2.45-$2.55 (from $2.40-$2.50); revenue guidance unchanged.
- Minimal impact to Q3 2025 adjusted EPS guidance from FTC action.

## SEC filing metadata
- accession: 0001099800-25-000046
- form_type: 8-K
- ticker: EW
- cik: 0001099800
- company_name: Edwards Lifesciences Corp
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1099800/000109980025000046/0001099800-25-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1099800/000109980025000046/ew-20250806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001099800-25-000046
- JSON: https://secwatch.observer/filing/0001099800-25-000046.json
- Plain text: https://secwatch.observer/filing/0001099800-25-000046.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.